Mike Moran, chief executive officer of Proton Partners International which operates the Rutherford Cancer Centres, said: “We are delighted to open our third Rutherford Cancer Centre in Reading and bring the most advanced cancer care to those in the South East. It is gratifying to see the speed at which each centre has been established, and our ultimate aim is to have a Rutherford Cancer Centre within 90 minutes of 75% of the UK population within the next three years.
“Reading is not only a dynamic city with a thriving healthcare and biotech scene, but one which is excellently located for patients to travel from Heathrow or other travel hubs. We see our Thames Valley centre as a gateway to proton beam therapy treatment, both for the UK as a whole and for patients from abroad.”